SEC Form 4 · accession 0001140361-16-048690
VASCULAR SOLUTIONS INC · VASC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Root
Officer — Chief Executive Officer · Director
Period of report
Jan 22, 2016
Accepted (ET)
Jan 26, 2016 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001030206
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 22, 2016 | A | 19,857 | — | A | 364,206 | D | |
| Common Stock | holding | — | — | — | 344,349 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | — | holding | — | — | — | — | Jan 27, 2022 | Common Stock | 450,000 | 450,000 | D |
Explanation of responses
- F1Represents restricted stock award that shall vest over four years at the rate of 50% on the second anniversary date of the award and 25% on each anniversary date thereafter; subject to continued employment.
- F290,000 shares vested on January 27, 2013 with an exercise price of $11.03/share. 90,000 shares vested on January 27, 2014 with an exercise price of $12.03/share. 90,000 shares vested on January 27, 2015 with an exercise price of $13.03/share. 90,000 shares vest on January 27, 2016 with an exercise price of $14.03/share. 90,000 shares vest on January 27, 2017 with an exercise price of $15.03/share.